Hamilton Beach Brands Holding Co. - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. Hamilton Beach Brands Holding Company operates as a leading designer, marketer, and distributor of small electric household appliances, commercial products, and healthcare management software. Operations are reported in two segments: Home and Commercial Products and Health. The Health segment was added as a reportable segment in Q4 2024 following the acquisition of HealthBeacon PLC.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue | $133.4 million | $128.3 million |
| Gross Profit | $32.8 million | $30.1 million |
| Gross Margin | 24.6% | 23.4% |
| Operating Profit | $2.3 million | ($0.9 million) Loss |
| Net Income | $1.8 million | ($1.2 million) Loss |
| Diluted EPS | $0.13 | ($0.08) |
| Operating Cash Flow | $6.6 million | $19.7 million |
| Cash and Equivalents | $48.3 million | $26.3 million |
| Debt (Revolving Credit) | $50.0 million | $50.0 million |
| Debt Availability | $72.6 million | N/A |
Material Changes vs. Prior Period
- Profitability Turnaround: The Company returned to profitability, reporting a net income of $1.8 million compared to a net loss of $1.2 million in Q1 2024. Operating profit improved by $3.3 million.
- Revenue Growth: Revenue increased 4.0% year-over-year, driven by favorable product mix and increased volume, partially offset by pricing pressures and foreign currency headwinds.
- Segment Performance: The Home and Commercial Products segment generated $3.2 million in operating profit, while the Health segment reported an operating loss of $0.9 million.
- Working Capital: Operating cash flow decreased significantly to $6.6 million from $19.7 million. This was primarily due to a $40.6 million cash outflow for inventory, as the Company pulled forward inventory ahead of potential tariff impacts.
- Share Repurchases: The Company repurchased 141,435 shares for $2.7 million under its authorized program, plus additional shares withheld for taxes, totaling $3.4 million in buybacks.
Outlook, Risks, and Management Commentary
- Seasonality: Management notes that revenue typically peaks in the fourth quarter due to the holiday season; Q1 results are not indicative of full-year performance.
- Tariff Risks: A significant risk factor is the impact of U.S. government trade actions. Approximately 75% of suppliers are based in China. The Company is evaluating the impact of baseline tariffs announced in April 2025 and reciprocal tariffs on countries with large trade deficits. Strategies include seeking exclusions and diversifying sourcing outside China.
- Liquidity: The Company maintains a $125 million revolving credit facility with $72.6 million in excess availability. Management believes cash on hand and facility access are sufficient for the next 12 months.
- Acquisition Integration: HealthBeacon contributed $1.5 million in revenue in Q1 2025. The Company is currently integrating HealthBeacon into internal control processes, with full inclusion in the internal control assessment expected by December 31, 2025.
Investor Verification Checklist
- Tariff Impact Analysis: Verify the specific financial impact of the April 2025 tariff announcements on the supply chain and cost of goods sold.
- Inventory Levels: Monitor inventory turnover and potential write-downs given the $40.6 million cash outflow for inventory buildup in Q1.
- Health Segment Margins: Track the profitability trajectory of the Health segment, which currently operates at a loss.
- Debt Covenants: Confirm continued compliance with the Fixed Charge Coverage Ratio covenant, which is triggered if excess availability falls below $15 million.
- Share Count: Verify the impact of ongoing share repurchases on diluted earnings per share.